奧特維(688516.SH):減持期過半 朱雄輝已減持26.33萬股
格隆匯9月12日丨奧特維(688516.SH)公佈,公司於2021年5月22日披露了《無錫奧特維科技股份有限公司董事、監事集中競價減持股份計劃公吿》(公吿編號:2021-020), 朱雄輝擬以集中競價的方式減持其所持有的公司股份不超過68.834萬股,擬減持股份佔公司股本比例不超過0.6976%;公司於2021年9月10日收到朱雄輝出具的《董事關於減持計進展的説明》,此次減持計劃時間已過半,其已減持26.33萬股,減持比例0.27%,減持計劃暫未實施完畢。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.